S-OA-I
Oral Abstracts - Session I - GVH/GVL & Immune Reconstitution
BMT Tandem "Scientific" Meeting
Texas D (Gaylord Texan)
Chairs:
Javier Bolaņos-Meade, MD
and
Krishna Komanduri, MD
Disclosures:
J. Bolaņos-Meade,
Nothing To Disclose
K. Komanduri,
Nothing To Disclose
Sensitization to HY-Antigen in Female Donors Was Not Associated with the Post-Transplant HY-IgG Development Nor Clinical Outcomes in Sex-Mismatched Transplantation
Hideki Nakasone, MD, PhD, Stanford University School of Medicine;
Bita Sahaf, PhD, Stanford University School of Medicine;
Lu Tian, Stanford University School of Medicine;
Tao Wang, PhD, Medical College of Wisconsin;
Michael Haagenson, MS, CIBMTR;
Rakesh Popli, Stanford University School of Medicine;
Joyce Lee, Stanford University School of Medicine;
Kelsi Schoenrock, Stanford University School of Medicine;
Spenser Perloff, Stanford University School of Medicine;
Prateek Joshi, Stanford University School of Medicine;
Joanne Otani, RN, MSN, PHN, Stanford University School of Medicine;
Fang Wu, Stanford University School of Medicine;
Stephen Spellman, MBS, CIBMTR/Minneapolis Campus;
Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center;
David B. Miklos, MD, PhD, Stanford University School of Medicine
Immunoregulatory B Cells Are Enriched within Transitional and IgM Memory B Cell Subsets in Healthy Donors but Are Reduced and Functionally Impaired in Patients with Chronic Graft-Versus-Host Disease
Anushruti Sarvaria, M.D. Anderson Cancer Center;
Ahmad Khoder, Imperial College London;
Abdullah Alsuliman, Imperial College London;
Claude Chew, MD Anderson Cancer Center;
Takuya Sekine, MD Anderson Cancer Center;
Nichola Cooper, Imperial College London;
Hugues de Lavallade, Imperial College London;
Muharrem Muftuoglu, MD Anderson Cancer Center;
Eric Yvon, MD Anderson Cancer Center;
Amir Hamdi, MD Anderson Cancer Center;
Amin M. Alousi, MD, UT MD Anderson Cancer Center;
Lisa St. John, PhD, MD Anderson Cancer Center;
David Marin, Imperial College London;
Kate Stringaris, Imperial College London;
Enli Liu, MD Anderson Cancer Center;
Jeffrey Molldrem, MD, MD Anderson Cancer Center;
Nina Shah, MD, MD Anderson Cancer Center;
Simrit Parmar, MD, UT M.D. Anderson Cancer Center;
Ian McNiece, PhD, MD Anderson Cancer Center;
Richard E. Champlin, MD, MD Anderson Cancer Center;
Elizabeth J. Shpall, MD, UT MD Anderson Cancer Center;
Katy Rezvani, MD, The University of Texas MD Anderson Cancer Center
The Role of Gut Microbiota in the Development of Intestinal Gvhd
Tiffany Simms-Waldrip, MD, Children's Medical Center;
Michal Meir, M.D., University of Texas Southwestern Medical Center;
Di Fan, University of Texas Southwestern Medical Center;
Laura Coughlin, University of Texas Southwestern Medical Center;
Milan Savani, University of Texas Southwestern Medical Center;
Tanya Watt, M.D., Children's Medical Center;
Victor Aquino, MD, University of Texas Southwestern Medical Center;
Andrew Young Koh, MD, University of Texas Southwestern Medical Center
Preventing Primate Gvhd Using a Novel Antagonistic Anti-CD28 Antibody Plus Rapamycin: Downregulation of CD8 Proliferation Predicts Gvhd-Free Survival
Benjamin K. Watkins, MD, Emory University;
Nicolas Poirier, Nantes University;
Caroline Mary, Effimune;
Gilles Blancho, Nantes University;
Karnail Singh, PhD, Emory University;
Aneesah Garrett, Emory University;
Kelly Hamby, Emory University;
Taylor Deane, Emory University;
Bruce R. Blazar, MD, University of Minnesota;
Bernard Vanhove, PhD, Nantes University;
Leslie S. Kean, MD, PhD, Ben Towne Center for Childhood Cancer Research, Seattle Childrens Research Institute
Immune Reconstitution after Autologous Stem Cell Transplantation for Multiple Myeloma
David J. Chung, MD, PhD, Memorial Sloan-Kettering Cancer Center;
Katherine B Pronschinske, Memorial Sloan-Kettering Cancer Center;
Justin A Shyer, Memorial Sloan-Kettering Cancer Center;
Vernon Wu, Memorial Sloan-Kettering Cancer Center;
Hani Hassoun, MD, Memorial Sloan-Kettering Cancer Center;
Heather Landau, MD, Memorial Sloan-Kettering Cancer Center;
Nikoletta Lendvai, MD, Memorial Sloan-Kettering Cancer Center;
Alexander M Lesokhin, MD, Memorial Sloan-Kettering Cancer Center;
Guenther Koehne, MD, PhD, Memorial Sloan-Kettering Cancer Center;
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center;
James W Young, MD, FACP, Memorial Sloan-Kettering Cancer Center
A 2-Step Approach to Haploidentical Versus Matched Related Hematopoietic Stem Cell Transplantation (HSCT): Equivalent Early Immune Reconstitution with Comparable Outcomes
Sameh Gaballa, MD, Kimmel Cancer Center, Thomas Jefferson University;
Matthew Carabasi, MD, Kimmel Cancer Center, Thomas Jefferson University;
Joanne Filicko, MD, Kimmel Cancer Center, Thomas Jefferson University;
Onder Alpdogan, MD, Kimmel Cancer Center, Thomas Jefferson University;
John L. Wagner, MD, Kimmel Cancer Center, Thomas Jefferson University;
Sarah Rosado, Kimmel Cancer Center, Thomas Jefferson University;
Shannon Rudolph, MS, Kimmel Cancer Center, Thomas Jefferson University;
Benjamin Leiby, Thomas Jefferson University;
Walter Kraft, MD, Thomas Jefferson University Hospital;
Margaret Kasner, MD, Kimmel Cancer Center, Thomas Jefferson University;
Ubaldo Martinez, MD, Kimmel Cancer Center, Thomas Jefferson University;
Mark Weiss, MD, Kimmel Cancer Center, Thomas Jefferson University;
Neal Flomenberg, MD, Kimmel Cancer Center, Thomas Jefferson University;
Dolores Grosso, DNP, Kimmel Cancer Center, Thomas Jefferson University
